Found 10 matching trials
Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)
PHASE2This Phase 2, multi-center, open-label extension trial will provide CAP-100...
Location
University of Florida
HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)
PHASE2Male participants with cardiomyopathy secondary to Duchenne muscular dystro...
Location
Cedars-Sinai Medical Center
CAP-1002 in Severe COVID-19 Disease
N/AThis expanded access protocol will enroll subjects with a clinical diagnosi...
Status
No Longer Available
Location
Cedars-Sinai Medical Center
A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
PHASE3HOPE-3 is a two cohort, Phase 3, multi-center, randomized, double-blind, pl...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)
PHASE1To determine the safety profile of CAP-1002 administered by multi-vessel in...
Location
Cedars-Sinai Medical Center
Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration
PHASE1The purpose of this study is to determine whether Allogeneic Cardiosphere-D...
Intravenous Infusion of CAP-1002 in Patients With COVID-19
PHASE2This is a randomized, double-blind, placebo-controlled, Pilot, Phase 2 Expl...
Location
Cedars-Sinai Medical Center
Open-label Extension of the HOPE-2 Trial
PHASE2This Phase 2, multi-center, open-label extension trial will provide deramio...
Status
Active Not Recruiting
Location
University of California, Davis
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy
PHASE1Pulmonary Arterial Hypertension or PAH is a progressive condition for which...
Location
Cedars-Sinai Medical Center
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
PHASE2HOPE-2 is a double-blind clinical trial evaluating the safety and efficacy ...
Location
University of California, Davis